3-D Sys Corp Del Stock Price, News & Analysis

3D Systems has announced Dr. Brent Stucker as the new Chief Scientist to enhance its leadership in additive manufacturing. Previously, he was the Director of Additive Manufacturing at Ansys and co-founded 3DSIM, a pioneer in AM simulation. Dr. Stucker, known for his extensive publications and contributions to industry standards, is set to drive innovation at 3D Systems. CEO Dr. Jeffrey Graves emphasized Stucker's unique qualifications to help meet customer needs and advance the entire additive industry.

3D Systems (NYSE: DDD) has expanded its materials portfolio by introducing Certified Scalmalloy and Certified M789, enhancing its Direct Metal Printing (DMP) capabilities. Scalmalloy features a tensile strength of 520MPa, ideal for aerospace and automotive applications, while M789 offers high-strength molds free of cobalt, certified for DMP. These innovations support faster time to market and improved manufacturing efficiency across various industries including aerospace, motorsports, and energy. Customers can leverage the Application Innovation Group's expertise to certify these materials effectively.

3D Systems Corporation (NYSE:DDD) reported strong Q2 2021 results, with revenue of $162.6 million, marking a 44.1% increase year-over-year. Adjusted EBITDA margin improved to 12.4%, and the company achieved a positive operating cash flow of $13.5 million. The growth was driven by a 68.6% rise in Healthcare revenue and 25.3% in Industrial sales. After divestitures, the balance sheet is set to improve, with cash projected to exceed $500 million. Despite a GAAP loss of $0.08 per share, the company remains optimistic about its growth trajectory and strategic focus on additive manufacturing.

3D Systems has announced the sale of its medical simulation business, Simbionix, to Surgical Science Sweden AB for $305 million. This divestiture is part of 3D Systems' strategy to focus exclusively on additive manufacturing. Following the transaction, 3D Systems will hold approximately $500 million in cash and have no debt. The company aims for growth and margin expansion in the additive manufacturing sector, emphasizing its industry-leading technology and operational efficiency. The completion of the transaction is expected in August 2021, with Simbionix reported sales of $40.8 million in 2020.

3D Systems has introduced the Accura AMX Rigid Black, a groundbreaking production-grade resin designed for large-scale 3D printing. This material, tested for up to eight years of indoor durability and one and a half years outdoors, enables the creation of highly complex, load-bearing parts. Customers across various sectors, including automotive and motorsports, can expect significant performance and cost improvements. The product will be available from July 20, 2021, with early adopters like TOYOTA Gazoo Racing already benefiting from its innovative capabilities.

3D Systems (DDD) announced its second-quarter financial results will be released after market close on August 9, 2021. Following this, a conference call is scheduled for August 10, 2021, at 8:30 a.m. Eastern Time to discuss the results. The company advises investors to consider forward-looking statements that involve risks and uncertainties affecting anticipated outcomes. These statements are based on current expectations and beliefs but may not guarantee future performance. Further details about 3D Systems' offerings in additive manufacturing are available on their website.

3D Systems (NYSE: DDD) announced a partnership with Rodin Cars to produce parts for their upcoming hypercar, the Rodin FZero, using advanced metal additive manufacturing solutions. The collaboration focuses on a first-of-its-kind 8-speed sequential gearbox, custom-designed to enhance performance and reduce weight through 3D printing in Titanium. This gearbox, along with hundreds of bespoke components, will be produced at Rodin's facility using 3D Systems' DMP Factory 500 technology, marking a significant advancement in additive manufacturing's application in high-performance automotive design.

3D Systems (NYSE: DDD) announces the appointment of Dr. David Leigh as Chief Technology Officer for Additive Manufacturing, enhancing innovation in production-scale solutions. Chuck Hull, co-founder, will shift focus to biotechnology, advancing regenerative medicine technologies. This leadership expansion aims to accelerate the company's innovation pace in response to the growing demand for additive manufacturing across healthcare and industrial sectors. Dr. Leigh brings over 30 years of experience, previously serving at EOS and Stratasys, and is expected to strengthen 3D Systems’ technological capabilities.

3D Systems (NYSE:DDD) and CollPlant Biotechnologies (NASDAQ:CLGN) have entered a co-development agreement to create a 3D bioprinted regenerative soft tissue matrix for breast reconstruction. This innovative product uses plant-based recombinant human collagen, aiming to improve healing outcomes and safety, while addressing supply shortages associated with traditional matrices. The partnership leverages both companies' expertise to develop a product that mimics patient anatomy and enhances implant procedures, catering to the growing market due to increasing breast cancer survival rates.